Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.

Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P.

Circulation. 2006 Oct 24;114(17):1829-37.

2.

Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.

Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P.

J Card Fail. 2009 Jun;15(5):442-50. doi: 10.1016/j.cardfail.2008.12.011.

PMID:
19477405
3.

Low circulating androgens and mortality risk in heart failure.

Güder G, Frantz S, Bauersachs J, Allolio B, Ertl G, Angermann CE, Störk S.

Heart. 2010 Apr;96(7):504-9. doi: 10.1136/hrt.2009.181065.

PMID:
19875366
4.

Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men.

Abbasi AA, Drinka PJ, Mattson DE, Rudman D.

J Am Geriatr Soc. 1993 Sep;41(9):975-82.

PMID:
8409184
5.

NT-proBNP, IGF-I and survival in patients with chronic heart failure.

Petretta M, Colao A, Sardu C, Scopacasa F, Marzullo P, Pivonello R, Fontanella L, de Caterina M, de Simone A, Bonaduce D.

Growth Horm IGF Res. 2007 Aug;17(4):288-96.

PMID:
17383209
6.

Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult men.

Friedrich N, Schneider HJ, Haring R, Nauck M, Völzke H, Kroemer HK, Dörr M, Klotsche J, Jung-Sievers C, Pittrow D, Lehnert H, März W, Pieper L, Wittchen HU, Wallaschofski H, Stalla GK.

Steroids. 2012 Jan;77(1-2):52-8. doi: 10.1016/j.steroids.2011.10.005.

PMID:
22037276
7.

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.

J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80.

8.

Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure.

Cicoira M, Rossi A, Bonapace S, Zanolla L, Golia G, Franceschini L, Caruso B, Marino PN, Zardini P.

J Card Fail. 2004 Oct;10(5):403-11.

PMID:
15470651
9.

[Are age and educational level the determinants of hormonal parameters considered as indices of andropause?].

Jankowska EA, Szklarska A, Lopuszańska M, Medraś M.

Pol Merkur Lekarski. 2004 Apr;16(94):323-7. Polish.

PMID:
15517925
10.

Testosterone level and mortality in elderly men with systolic chronic heart failure.

Wu HY, Wang XF, Wang JH, Li JY.

Asian J Androl. 2011 Sep;13(5):759-63. doi: 10.1038/aja.2011.26.

11.

Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure.

Rydlewska A, Maj J, Katkowski B, Biel B, Ponikowska B, Banasiak W, Ponikowski P, Jankowska EA.

Aging Male. 2013 Jun;16(2):58-66. doi: 10.3109/13685538.2013.768979.

PMID:
23581721
12.

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P.

Circulation. 2005 Sep 20;112(12):1756-62.

13.

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.

Güder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Störk S.

Circulation. 2007 Apr 3;115(13):1754-61.

14.

Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency?

Van Den Saffele JK, Goemaere S, De Bacquer D, Kaufman JM.

Clin Endocrinol (Oxf). 1999 Jul;51(1):81-8.

PMID:
10468969
15.

Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.

George J, Patal S, Wexler D, Abashidze A, Shmilovich H, Barak T, Sheps D, Keren G.

Arch Intern Med. 2005 Jun 13;165(11):1304-9.

PMID:
15956012
16.

Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women.

Abbasi A, Duthie EH Jr, Sheldahl L, Wilson C, Sasse E, Rudman I, Mattson DE.

J Am Geriatr Soc. 1998 Mar;46(3):263-73.

PMID:
9514370
17.

Regular moderate intensity physical activity and blood concentrations of endogenous anabolic hormones and thyroid hormones in aging men.

Ravaglia G, Forti P, Maioli F, Pratelli L, Vettori C, Bastagli L, Mariani E, Facchini A, Cucinotta D.

Mech Ageing Dev. 2001 Feb;122(2):191-203.

PMID:
11166358
18.

Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly?

Kalicińska E, Wojtas K, Majda J, Doehner W, von Haehling S, Banasiak W, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Ponikowski P, Jankowska EA.

Aging Male. 2013 Sep;16(3):123-31. doi: 10.3109/13685538.2013.807427.

PMID:
23803163
19.

Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.

Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.

Am J Cardiol. 2008 Aug 15;102(4):469-74. doi: 10.1016/j.amjcard.2008.03.082.

PMID:
18678308
20.

Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.

Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC.

J Am Coll Cardiol. 2007 Sep 11;50(11):1054-60.

Items per page

Supplemental Content

Support Center